BASIL 2 - A vein bypass first versus a best endovascular treatment first revascularisation strategy for patients with chronic limb threatening ischaemia who required an infra-popliteal, with or without an additional more proximal infra-inguinal revascularisation procedure to restore limb perfusion: an open-label, randomised, multicentre, phase 3 trial (www.thelancet.com/journals/la...)
In this video the BASIL 2 trial is presented by the Chief Investigator Prof Andrew Bradbury. To understand the key messages and see where the trial has been misunderstood, we take a deeper dive into the study and the topic of Chronic Limb Thgreatening Ischaemia and its management. At the end we explore the planned future analyses and I include my thoughts on the key take home messages and implications for your practice.
Huge thanks to Professor Bradbury and to the expert panel for really bringing this topic to life. This video has been hugely beneficial in my understanding of this landmark trial.
This video is presented by:
Dan Carradice - Vascular Surgical Specialty Lead - Royal College or Surgeons of England
Paddy Coughlin - Co Chair Peripheral Vascular Disease Special Interest Group of the Vascular Society of Great Britian and Ireland
Kaji Sritharan - Council member of the Vascular Society of Great Britian and Ireland
Thanos Saratzis - Co Chair Peripheral Vascular Disease Special Interest Group of the Vascular Society of Great Britian and Ireland
....on behalf of Vascular Research UK
Edited by:
Louise Hitchman NIHR DRF (massive thanks)
Dan Carradice
Please like, subscribe, share and click notifications. We want to hear your comments questions and discussion below.
00:00 Introduction
01:34 BASIL-2 Trial introduction
02:11 What we learned from BASIL - 1
04:06 BASIL - 2 Non randomised prospective cohort study
07:08 BASIL - 2 Results
16:37 Discussion
01:04:48 Take Home Messages
5 авг 2024
